Topical Eczema Treatment Satisfaction: What 267 US Patients and Caregivers Said
Editorial image disclosure: the featured image is AI-created. Dr. Arsy #003 was not the study product.
The 2025 US survey included 267 adolescents and adults with moderate-to-severe atopic dermatitis who were using topical therapy alone or alongside advanced systemic treatment. 1234
Key findings and limitations
Sixty-eight percent reported disliking how topical treatment felt on the skin. Agreement between clinicians and patients/caregivers was only fair to moderate for satisfaction and some instruction domains, with weaker concordance in severe disease and combined-therapy groups. 5678
What the broader evidence adds
Guidelines, burden studies and preference research answer different questions. Cohorts and surveys describe patterns; randomized trials are needed for treatment effects; patient priorities still matter when options have different routes, monitoring and tradeoffs. 910111213
Practical interpretation
Vehicle, greasiness, stinging, time, clothing transfer, amount and frequency can determine whether a theoretically effective plan is usable. Ask the patient to demonstrate application and describe what happens on a real weekday, not an ideal one. 14151617
Safety boundary
Do not discontinue prescription treatment solely because of texture without discussing alternatives. Burning, swelling, hives, infection or unexpected worsening needs medical advice. Findings from one population should not be transferred automatically to every baby, child or adult. 18192021
Where #003 fits
Dr. Arsy Moisturizer #003, 4 oz is an optional cosmetic moisturizer for dry, sensitive and eczema-prone skin. It was not evaluated in the cited study and is not claimed here to treat, cure or prevent eczema or another condition.
Related Dr. Arsy research guides
- 2026 pediatric topical guideline
- 2026 pediatric systemic guideline
- Adult guideline update
- Skin infection update
- Adult quality of life in Japan
- Childhood quality of life
- Eczema and sleep disorders
- Choosing an eczema moisturizer
References
- Skin microbiome resilience during topical treatment
- Pediatric dupilumab response across racial and ethnic groups
- Burden of mild and moderate atopic dermatitis in US adults
- Caregiver-reported access to mental health services
- Topical therapy experience, satisfaction and communication
- International patient and caregiver education-needs survey
- Type 2 diabetes risk in atopic dermatitis: age-stratified TriNetX analysis
- Adult eczema, oral health and oral dysbiosis case-control study
- Disease control, perceived risk and treatment decisions
- Pediatric, young-adult and caregiver treatment goals
- Preferences in atopic dermatitis: systematic review
- Adult AAD focused guideline update
- Pediatric AAD management guideline
- Pediatric prevention and comorbidity guideline
- Mental-health burden in atopic dermatitis
- Atopic dermatitis and sleep disorders: UK Biobank
- Patient treatment needs in TREATgermany
- Online versus in-person eczema care randomized trial
- Infectious complications of atopic dermatitis update
- 71-outcome UK eczema cohort program
- US Optum disease-event cohort